World Intellectual Property Organization

Wesana Completes Filing of PCT Patents for Novel Drug Protocols

Retrieved on: 
Thursday, December 9, 2021
SEDAR, Anxiety, Terminology, Forward-looking statement, Company, Research, GLOBE, Fungus, CSE, Patent Cooperation Treaty, Mental health, World Intellectual Property Organization, Migraine, News, CEO, PCT, Depression, Corporation, Patent, Psilocybin, WESA, TBI, Hope, Traumatic brain injury, Solution, Risk, Pharmaceutical industry, 3D printing

This PCT application, filed with the World Intellectual Property Organization will enable Wesana to file patent applications and seek protection in most major markets throughout the world.

Key Points: 
  • This PCT application, filed with the World Intellectual Property Organization will enable Wesana to file patent applications and seek protection in most major markets throughout the world.
  • Overall, any patent efforts in relation to the foregoing are at the patent application stage.
  • Since we began our research at Wesana, our goal remains to find novel therapies to help other sufferers of TBI and mental health challenges find hope through effective healing medicine and therapies, said Daniel Carcillo, Wesana founder and CEO.
  • This press release includes statements or information which may constitute forward-looking information within the meaning of applicable Canadian securities laws.

PyroGenesis Announces the Launch of a New ZCE Hydrogen Production Process Following the Filing of International Patent Applications

Retrieved on: 
Wednesday, December 8, 2021
European Union, GHG, Forward-looking statement, Company, 0 A.D. (video game), Paris, Hydrogen, Carbon, Research, GLOBE, Technology, Iron, Natural gas, Toronto Stock Exchange, Coal, Union, Nasdaq, Oxygen, Paris Agreement, Plasma, Waste management, World Intellectual Property Organization, Methane, CEO, Heat, ZCE, Hydrocarbon, TSX, Greenhouse gas, PCT, Transport, Climate, Aluminium, ISO, ISO 9001:2015, LLC, Greenhouse, WIPO, FRA, NASDAQ, Water, Electricity, Solution, Oil

PyroGenesis new hydrogen production technology is now entering a testing phase and is expected to convert methane (a GHG with a high global warming potential) to hydrogen, thereby creating a ZCE hydrogen.

Key Points: 
  • PyroGenesis new hydrogen production technology is now entering a testing phase and is expected to convert methane (a GHG with a high global warming potential) to hydrogen, thereby creating a ZCE hydrogen.
  • The conventional ZCE process, water electrolysis, is extremely expensive, requires a lot of energy and uses rare earth materials.
  • PyroGenesis new technology is expected to combine the best of both worlds; it is expected to be cheaper than any existing hydrogen process while at the same time producing ZCE hydrogen.
  • We believe our new proprietary hydrogen production process will be much more energy efficient, cost-effective and scalable than other forms of hydrogen production.

Mydecine Reports Third Quarter 2021 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, November 16, 2021
PTSD, Adoption, Drug development, Science, Anxiety, Medicine, Digital technology, Depression, FSE, CEO, Technology, Research, NEO, NIDA, World Intellectual Property Organization, Biotechnology, Mental health, Company, JHU, GLOBE, Therapy, Addiction, Smoking, United States Patent and Trademark Office, Patent, Patient, OTC, FDA, Johns Hopkins School of Medicine, Pharmaceutical industry

DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today reported its financial results for the third quarter ended September 30, 2021 and provided a business update.

Key Points: 
  • DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (Mydecine or the Company), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today reported its financial results for the third quarter ended September 30, 2021 and provided a business update.
  • Prepared to supply its lead drug candidate, MYCO-001, for a JHU multi-site NIDA grant-funded smoking cessation study led by Dr. Matthew Johnson.
  • Mydecine Innovations Group's vision is to bridge the current gap between what the mental healthcare system currently provides with the needs of the patients.
  • Mydecine Innovations Group is headquartered in Denver, Colorado, USA with international offices in Leiden, Netherlands.

Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation

Retrieved on: 
Wednesday, November 10, 2021
ART, Patent Cooperation Treaty, Form, Cannula, WIPO, Unitary state, Proton Inspira, Infection, CEO, PCT, Food, OXY, Regulation of tobacco by the U.S. Food and Drug Administration, Human, Risk, World Intellectual Property Organization, Carbon, Company, Failure rate, Oxygen, SEC, Physician, Patent, Bleeding, Patient, FDA, Medical imaging, Pharmaceutical industry

The main potential advantage of Inspira Technologies' innovative dual lumen cannula lies in the user experience (i.e.

Key Points: 
  • The main potential advantage of Inspira Technologies' innovative dual lumen cannula lies in the user experience (i.e.
  • Dual lumen cannula insertion resembles the technique used for single lumen cannula insertion.
  • Inspira Technologies' dual lumen cannula is designed to reduce complications such as bleeding and infection, improving patient outcomes.
  • Inspira Technologies' dual lumen cannula can be inserted into a large blood vessel without fluoroscopic guidance, at the patient's bedside.

Energy And Water Development Receives Global Trademark Protection for Their Name and Logo

Retrieved on: 
Friday, November 5, 2021
Maintenance, Carbon footprint, WIPO, News, Engineering, Non-governmental organization, Master of Science, Energy and Water Development and Related Agencies Appropriations Act, 2014, Water, Drinking, Atmosphere, World Intellectual Property Organization, Company, GLOBE, Solution, Petersburg, Gigafactory, Renewable energy

Saint Petersburg, Florida, Nov. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Energy And Water Development (EAWD) is pleased to announce the companys filing for global trademark protection of their name and logo has been accepted.

Key Points: 
  • Saint Petersburg, Florida, Nov. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Energy And Water Development (EAWD) is pleased to announce the companys filing for global trademark protection of their name and logo has been accepted.
  • This comes on the heels of the acceptance of their international patent application by the World Intellectual Property Organization (WIPO).
  • The eAWG system overcomes the two main challenges of atmosphere water generation process: energy consumption and a large carbon footprint.
  • Energy And Water Development is an engineering solutions company focused on delivering innovative and sustainable solutions of water and energy.

Dogtown Media CEO to speak at digital roundtable regarding intellectual property for mobile applications with Trinidad and Tobago entrepreneurs, hosted by WIPO

Retrieved on: 
Thursday, November 4, 2021
ACT, World Intellectual Property Organization, Compliance, Entrepreneurship, Association, WIPO, United Nations, IP, Health care, Partnership, First Nations in Ontario, Thought, Corporate Affairs and Intellectual Property Office, CEO, Environment, Intellectual property, IPOPHL, IOT, Artificial intelligence, Video game, Mobile phone

Today, developers must consider the security of user data, compliance as well as protecting intellectual property.

Key Points: 
  • Today, developers must consider the security of user data, compliance as well as protecting intellectual property.
  • "Entrepreneurs should be thinking about the intellectual property contained in their mobile app, early and often.
  • The World Intellectual Property Organization or WIPO is a global forum that addresses topics and policies related to intellectual property.
  • To date, Dogtown Media has created over 250 mobile apps in industries including Healthcare app development , IoT, and Artificial Intelligence .

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Retrieved on: 
Wednesday, September 22, 2021
Patent, WIPO, OTC, Anxiety, Therapy, Depression, Patient, USPTO, United States Patent and Trademark Office, GLOBE, CEO, Happiness, Company, Mental health, Risk, Technology, Post-traumatic stress disorder, Research, PTSD, Safety, NEO, World Intellectual Property Organization, Psilocybin, Addiction, Pharmaceutical industry

In addition, the Company is pleased to report positive preclinical data supporting the continued development of MYCO-003.

Key Points: 
  • In addition, the Company is pleased to report positive preclinical data supporting the continued development of MYCO-003.
  • This patent pending formulation has the potential to further reduce patient anxiety as compared to pure psilocybin, when used in therapy or medical practice.
  • Mydecine believes these properties will be synergistic and particularly important for the effective treatment of patients with severe PTSD and extreme anxiety disorders.
  • Mydecine Innovations Group is headquartered in Denver, Colorado, USA with international offices in Leiden, Netherlands.

Global Ophthalmic Drug Delivery Devices Market (2021 to 2030) - Focus on Product, Formulation, Sales Channel, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 14, 2021
Pharmaceutical, Optical, Health, Medical Devices, Prevalence, Syringe, WIPO, Medicine, World Intellectual Property Organization, Nanotechnology, Growth, Technology, COVID-19, CAGR, Medical device, Pharmaceutical industry, Healthcare

The scope of the global ophthalmic drug delivery devices market involves various drug delivery devices used in ophthalmic drug delivery.

Key Points: 
  • The scope of the global ophthalmic drug delivery devices market involves various drug delivery devices used in ophthalmic drug delivery.
  • The restraints for the global ophthalmic drug delivery devices market include high upfront cost of the advanced ophthalmic drug delivery devices and prolonged regulatory approval process.
  • Entry of regional companies in the global ophthalmic drug delivery devices market, partnerships between companies and ophthalmic clinics, and inclusion of nanotechnology in ophthalmic drugs formulation are the key opportunity areas in the global ophthalmic drug delivery devices market.
  • Key technology trends such as the sustained drug delivery, connected devices for medication adherence, small molecules for drug delivery, and liquid sprays are anticipated to influence the global ophthalmic drug delivery devices market.

Energy And Water Development Receives Global Patent Protection For Energy-Free Water Generation Technology

Retrieved on: 
Tuesday, September 7, 2021

HAMBURG, Germany, Sept. 7, 2021 /PRNewswire/ -- Energy And Water Development (EAWD) is pleased to announce the international patent application for their self-sufficient, energy-supplied Atmosphere Water Generation system has been accepted by the World Intellectual Property Organization (WIPO).

Key Points: 
  • HAMBURG, Germany, Sept. 7, 2021 /PRNewswire/ -- Energy And Water Development (EAWD) is pleased to announce the international patent application for their self-sufficient, energy-supplied Atmosphere Water Generation system has been accepted by the World Intellectual Property Organization (WIPO).
  • This patent protects the innovative technology that overcomes the two main challenges of atmosphere water generation: energy consumption and a large carbon footprint.
  • "The acceptance of our global patent application allows us to move forward rapidly with the development and deployment of our self-sufficient energy supplied Atmosphere Water Generators."
  • For more information about EAWD and all their innovative solutions to world energy and water issues, please visit https://energy-water.com/
    Energy And Water Development is an engineering solutions company focused on delivering innovative and sustainable solutions of water and energy.

Energy And Water Development (EAWD:OTC) Receives Global Patent Protection For Energy-Free Water Generation Technology

Retrieved on: 
Tuesday, September 7, 2021

St. Petersburg, Florida, Sept. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Energy And Water Development (EAWD) is pleased to announce the international patent application for their self-sufficient, energy-supplied Atmosphere Water Generation system has been accepted by the World Intellectual Property Organization (WICO).

Key Points: 
  • St. Petersburg, Florida, Sept. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Energy And Water Development (EAWD) is pleased to announce the international patent application for their self-sufficient, energy-supplied Atmosphere Water Generation system has been accepted by the World Intellectual Property Organization (WICO).
  • This patent protects the innovative technology that overcomes the two main challenges of atmosphere water generation: energy consumption and a large carbon footprint.
  • The acceptance of our global patent application allows us to move forward rapidly with the development and deployment of our self-sufficient energy supplied Atmosphere Water Generators, said Irma Velazquez, MSc - COO.
  • For more information about EAWD and all their innovative solutions to world energy and water issues, please visit https://energy-water.com/
    Energy And Water Development is an engineering solutions company focused on delivering innovative and sustainable solutions of water and energy.